AstraZeneca opened a new $224 million drug manufacturing and packaging factory in Russia on Tuesday in a move Chief Executive Pascal Soriot said reinforced its long-term commitment to the country.
In 2011, the British-based group was one of the first multinational companies to announce plans to step up medicine production in Russia following moves by Moscow to support local industry by imposing tougher rules on imported drugs.
It is the largest foreign investment in the construction of a new pharmaceutical facility in the country.
Help employers find you! Check out all the jobs and post your resume.
In 2011, the British-based group was one of the first multinational companies to announce plans to step up medicine production in Russia following moves by Moscow to support local industry by imposing tougher rules on imported drugs.
It is the largest foreign investment in the construction of a new pharmaceutical facility in the country.
Help employers find you! Check out all the jobs and post your resume.
